PlexPrime® products – powered by PlexZyme® & PlexPrime® technology – offer superior multiplex mutation detection. Our patented priming approach generates unique amplicons for target specific amplification and detection, improving specificity even across clustered mutations. Multiplexing key mutations for single-well detection further streamlines your testing process.
Choose PlexPrime® technology and place your lab at the forefront of SARS-CoV-2 mutation detection.
PlexPrime® SARS-CoV-2 Genotyping reagents are designed to detect mutations associated with variants of concern (VOC). VOCs are linked to increased transmissibility or severity of disease. PlexPrime® mutation detection products generate actionable, reportable data in only a few hours, enabling proactive management of public health crises.
Improve throughput and minimise hands-on time by reducing the number of reflex reactions required in your variant investigations.
PlexPrime® SARS-CoV-2 Genotyping allows for detection of multiple mutations linked to VOC in a single well using only a small amount of sample extract.
Reduce the cost, time, and complexity of sequence-based variant analysis. Sequencing is key to support ongoing variant monitoring, but is an unsustainable long-term solution for large amounts of SARS-CoV-2- positive samples.
Use PlexPrime® SARS-CoV-2 Genotyping products to identify key mutations and clear a path for sequencing the correct positive samples.
We routinely monitor and assess emerging variants of concern and high consequence, to continually develop appropriate detection tools for key mutations. The versatility of our PlexPrime® technology supports rapid evolution of our SARS-CoV-2 Genotyping solutions as additional variants of concern are designated.
Supply chains have been increasingly strained throughout the COVID-19 pandemic. SpeeDx PlexPCR® technology de-couples the detection probe from the target sequence – resulting in universal probes suited for multiple assays and applications.